Earnings Feed
Start Free
Home/Filings/4/0001127602-22-013519
4//SEC Filing

LeCointe-Cephas Lisa 4

Accession 0001127602-22-013519

CIK 0000310158other
View on SEC.govCompany Profile

Filed

May 4, 8:00 PM ET

Accepted

May 5, 5:04 PM ET

Size

13.8 KB

Accession

0001127602-22-013519

Insider Transaction Report

Form 4
Period: 2022-05-03
Merck & Co., Inc.MRK
LeCointe-Cephas Lisa
SVP Chief Ethics & Com Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-05-04$87.10/sh+813$70,812→ 3,942.781 total
  • Tax Payment

    Common Stock

    2022-05-04$87.10/sh−279$24,301→ 3,663.781 total
  • Award

    Stock Option (Right to Buy)

    2022-05-03+11,650→ 11,650 total
    Exercise: $87.10From: 2023-05-03Exp: 2032-05-02→ Common Stock (11,650 underlying)
  • Award

    Restricted Stock Unit

    2022-05-03+2,067→ 2,067 total
    From: 2023-05-03Exp: 2025-05-03→ Common Stock (2,067 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2022-05-04−813→ 1,629 total
    From: 2022-05-04Exp: 2024-05-04→ Common Stock (813 underlying)
Footnotes (6)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024, and 5/3/2025.
  • [F5]Holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. ("Organon") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the "Form 10"). As reported in the Form 10, all Merck restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments.
  • [F6]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Documents

1 file

Issuer

Merck & Co., Inc.

CIK 0000310158

→
Entity typeother

Related Parties

1
  • filerCIK 0001854644

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:04 PM ET
Size
13.8 KB
View on SEC.gov